Novartis cuts New Jersey jobs; OTR, LG Chem explore China cancer drugsnews2026-07-08T14:30:27+00:00July 8th, 2026|Endpoints News|
MeiraGTx strikes royalty deal; Fore’s 2023 Series D continuesnews2026-07-07T14:38:56+00:00July 7th, 2026|Endpoints News|
Apogee details path to $10.9B AbbVie deal; UK starts drug pricing pilotnews2026-07-06T14:46:54+00:00July 6th, 2026|Endpoints News|
Vertex’s sickle cell therapy approved for kids; United Therapeutics buys startupnews2026-07-02T14:10:44+00:00July 2nd, 2026|Endpoints News|
Angitia ends Phase 3 in disc disease; Abivax targets $800M on colitis datanews2026-07-01T13:29:11+00:00July 1st, 2026|Endpoints News|
Sarepta’s FDA decision date; Flare gets Anna Protopapas as CEOnews2026-06-30T14:43:09+00:00June 30th, 2026|Endpoints News|
Biotech SPAC deal gets it to Nasdaq; AstraZeneca Phase 3 win in bone diseasenews2026-06-29T14:34:11+00:00June 29th, 2026|Endpoints News|
Recordati licenses Ionis drug; Vaxart’s BARDA funding is cutnews2026-06-25T15:28:54+00:00June 25th, 2026|Endpoints News|
Verastem’s KRAS G12D vision; ADC Therapeutics reorganizes, lays off 17% of staffnews2026-06-24T14:17:56+00:00June 24th, 2026|Endpoints News|
Boundless Bio reverse merger; CARsgen wins first solid tumor approval for CAR-Tnews2026-06-23T15:12:38+00:00June 23rd, 2026|Endpoints News|
